SUMMIT GLOBAL INVESTMENTS – Eagle Pharmaceuticals, Inc. Transaction History
SUMMIT GLOBAL INVESTMENTS portfolio value:
$907,000
portfolio value
SUMMIT GLOBAL INVESTMENTS quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.74% | 587 shares | -592K | $26.42 | 34.32K |
| Q2 2022 | share | Increase | +4.83% | 1.55K shares | -94K | $44.43 | 33.73K |
| Q1 2022 | share | Decrease | -9.90% | -3.53K shares | -226K | $49.49 | 32.18K |
| Q4 2021 | share | Decrease | -4.03% | -1.5K shares | -257K | $51.1 | 35.71K |
| Q3 2021 | share | Increase | +18.37% | 5.77K shares | 612K | $55.78 | 37.21K |
| Q4 2020 | share | Increase | +4.16% | 1.25K shares | 182K | $46.57 | 31.44K |
| Q3 2020 | share | Increase | +7.82% | 2.18K shares | -61K | $42.48 | 30.18K |
| Q2 2020 | share | Increase | +97.18% | 13.8K shares | 690K | $47.98 | 28K |
| Q1 2020 | share | Increase | 0.00% | 14.2K shares | 653K | $46 | 14.2K |